"What this would mean for me as a researcher is that, essentially, all the work that I do is going to stop in its tracks. Fogarty is really the glue globally for the NIH. It would mean the end of support for researchers in-country who are building up the infrastructure for research; it’s the end of collaborations that have been built over decades. It’s also the end of growing a new generation of researchers who are committed to global health. I really think the ripple effects of this are beyond what we can imagine."